Published
Biogen’s market value rose $11 bln on news its new treatment for Alzheimer's disease appeared effective. Robert Cyran explains why this rise is rather cautious, and how the drug might exceed Wall Street’s assumptions.
#Biogen #Alzheimer #Business #News #Reuters #newsfeed
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
#Biogen #Alzheimer #Business #News #Reuters #newsfeed
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
01:32
Biogen CEO to step down after Alzheimer's drug snags
-
02:34
Wall Street vs Main Street: GameStop's shares shoot up again
-
02:04
U.S. retail sales exceed expectations in October
-
00:48
Biogen Alzheimer's drug closer to approval
-
01:44
Apple, Facebook top Wall Street expectations
-
01:59
Biogen shares soar on landmark Alzheimer's data
-
01:12
First patient receives Biogen Alzheimer's drug
-
01:56
Apple, Alphabet miss Wall Street expectations
-
01:02
European panel votes against Biogen’s Alzheimer’s drug
-
02:07
UK Alzheimer's patient positive after Biogen trials
-
01:17
FDA narrows patient group for Biogen's Alzheimer's drug
-
02:01
Biogen to ship Alzheimer's drug in two weeks
-
01:33
Breakingviews TV: Biogen’s drug
-
10:00
Lee Zeldin will ‘exceed’ expectations in NY, former governor predicts
-
03:31
FDA approves controversial Biogen Alzheimer's drug | DW News
-
04:45
‘TAKING JOBS’: This is going to further divide Main Street and Wall Street: Expert
-
16:02
What’s The Controversy Behind Biogen’s Alzheimer’s Drug?
-
12:34
An Alzheimer’s Drug That Doesn’t Treat Alzheimer’s?
-
08:30
Biogen Probed Over Price Gouging Dangerous Alzheimer’s Drug
-
01:00
Nvidia forecast tops Wall Street expectations
-
08:27
Trump Warned Wall Street But Lied To Main Street About COVID-19
-
01:58
Wall Street rallies as Fed minutes meet expectations
Loading...